Variant report
Variant | nsv518538 |
---|---|
Chromosome Location | chr6:30983326-30991559 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:30781714..30783791-chr6:30982862..30984438,2 | K562 | blood: | |
2 | chr6:30989389..30991180-chr6:30994181..30996114,2 | K562 | blood: | |
3 | chr6:26026654..26028309-chr6:30981430..30984025,2 | K562 | blood: | |
4 | chr6:30975520..30978451-chr6:30989094..30991003,2 | K562 | blood: | |
5 | chr6:30971805..30974320-chr6:30984460..30987060,2 | K562 | blood: | |
6 | chr6:30990191..30992901-chr6:31003159..31005249,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261272 | chromatin interactions |
ENSG00000124529 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1619376 | chr6:30983326-30983327 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs28360980 | chr6:30983348-30983349 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs114576318 | chr6:30983362-30983363 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs9262468 | chr6:30983417-30983418 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs536784700 | chr6:30983478-30983479 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs558297385 | chr6:30983479-30983480 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs3871465 | chr6:30983504-30983505 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs541275380 | chr6:30983524-30983525 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs28360981 | chr6:30983581-30983582 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs574715036 | chr6:30983618-30983619 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs35073882 | chr6:30983640-30983641 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs373206425 | chr6:30983647-30983648 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs116559107 | chr6:30983665-30983666 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs3871466 | chr6:30983683-30983684 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs58389965 | chr6:30983692-30983693 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs148105221 | chr6:30983778-30983779 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs201051754 | chr6:30983789-30983790 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs560791400 | chr6:30983847-30983848 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs377185834 | chr6:30983848-30983849 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs201671230 | chr6:30983858-30983859 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs73727156 | chr6:30983865-30983866 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs201494313 | chr6:30983869-30983870 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs56183784 | chr6:30983895-30983896 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs28993413 | chr6:30983910-30983911 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs374309527 | chr6:30983921-30983922 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs573384796 | chr6:30983923-30983924 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs568658072 | chr6:30983948-30983949 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs568715850 | chr6:30983952-30983953 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs529622130 | chr6:30984014-30984015 | ZNF genes & repeats Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs540722102 | chr6:30984016-30984017 | ZNF genes & repeats Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs547768805 | chr6:30984037-30984038 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73395840 | chr6:30984078-30984079 | ZNF genes & repeats Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs553366205 | chr6:30984099-30984100 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536723146 | chr6:30984125-30984126 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7776233 | chr6:30984128-30984129 | ZNF genes & repeats Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs142977195 | chr6:30984145-30984146 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534511424 | chr6:30984161-30984162 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192966076 | chr6:30984241-30984242 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs377460701 | chr6:30984260-30984261 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574621122 | chr6:30984281-30984282 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13190971 | chr6:30984319-30984320 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372220195 | chr6:30984323-30984324 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs13206688 | chr6:30984341-30984342 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542176938 | chr6:30984346-30984347 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564307080 | chr6:30984380-30984381 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs3869096 | chr6:30984404-30984405 | ZNF genes & repeats Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs9262470 | chr6:30984422-30984423 | ZNF genes & repeats Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs116137250 | chr6:30984425-30984426 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs59723032 | chr6:30984426-30984427 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs60138183 | chr6:30984436-30984437 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Breast cancer | 21364760 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:30972600-30997600 | Weak transcription | Right Atrium | heart |
2 | chr6:30984000-30985000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr6:30986000-30986200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:30987800-30988400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr6:30988000-30988200 | Flanking Bivalent TSS/Enh | HUES48 Cell Line | embryonic stem cell |
6 | chr6:30988000-30988400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
7 | chr6:30988200-30988400 | Flanking Active TSS | H1 Cell Line | embryonic stem cell |
8 | chr6:30988200-30988400 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
9 | chr6:30988200-30988400 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr6:30988200-30988600 | Active TSS | HUES48 Cell Line | embryonic stem cell |
11 | chr6:30988200-30988600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr6:30988200-30988600 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
13 | chr6:30988400-30988800 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
14 | chr6:30988400-30988800 | Active TSS | H1 Cell Line | embryonic stem cell |
15 | chr6:30988400-30988800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr6:30988400-30988800 | Flanking Bivalent TSS/Enh | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr6:30988400-30989000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
18 | chr6:30988600-30988800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
19 | chr6:30988600-30988800 | Bivalent Enhancer | Esophagus | oesophagus |
20 | chr6:30988600-30989000 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr6:30988800-30989000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
22 | chr6:30989000-30993400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |